Virtual Library

Start Your Search

  • WCLC 2016

    17th World Conference on Lung Cancer

    Access to all presentations that occur during the 17th World Conference on Lung Cancer in Vienna, Austria

    Presentation Date(s):  
    • Dec 4 - 7, 2016
    • Total Presentations: 2466

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

Filter Results:

Show Only Available Presentations

  • +

    OA05 - Treatment Advances in SCLC

    • Type: Oral Session
    • Track: SCLC/Neuroendocrine Tumors
    • Presentations: 8
    • Moderators:A. Ardizzoni
    • Coordinates: 12/05/2016, 14:20 - 15:50, Strauss 2
    • +

      OA05.03 - Single-Agent Rovalpituzumab Tesirine, a Delta-Like Protein 3 (DLL3)-Targeted Antibody-Drug Conjugate (ADC), in Small-Cell Lung Cancer (SCLC)

      14:40 - 14:50  |  Author(s): D.R. Spigel

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    SC12 - Anticancer Drug Development in the 21st Century

    • Type: Science Session
    • Track: Chemotherapy/Targeted Therapy/Immunotherapy
    • Presentations: 5
    • Moderators:L. Einhorn
    • Coordinates: 12/05/2016, 16:00 - 17:30, Hall C2
    • +

      SC12.02 - Molecular-Based Therapy of Lung Cancer: The Way Forward?

      16:25 - 16:45  |  Author(s): C. Rudin

      • Abstract
      • Presentation
      • Slides

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA11 - Angiogenesis in Advanced Lung Cancer

    • Type: Oral Session
    • Track: Advanced NSCLC
    • Presentations: 8
    • Moderators:L.M. Montuenga
    • Coordinates: 12/06/2016, 11:00 - 12:30, Stolz 2
    • +

      OA11.05 - A Phase 2 Study of Cabozantinib for Patients with Advanced RET-Rearranged Lung Cancers

      11:35 - 11:45  |  Author(s): A. Drilon

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MA11 - Novel Approaches in SCLC and Neuroendocrine Tumors

    • Type: Mini Oral Session
    • Track: SCLC/Neuroendocrine Tumors
    • Presentations: 12
    • Moderators:P. Lara
    • Coordinates: 12/06/2016, 14:20 - 15:50, Strauss 3
    • +

      MA11.07 - Improved Small Cell Lung Cancer (SCLC) Response Rates with Veliparib and Temozolomide: Results from a Phase II Trial

      15:02 - 15:08  |  Author(s): L.A. Byers

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    OA19 - Translational Research in Early Stage NSCLC

    • Type: Oral Session
    • Track: Early Stage NSCLC
    • Presentations: 8
    • Moderators:G. Heller
    • Coordinates: 12/07/2016, 11:00 - 12:30, Schubert 3
  • +

    P3.02c - Poster Session with Presenters Present

    • Type: Poster Presenters Present
    • Track: Advanced NSCLC
    • Presentations: 103
    • Coordinates: 12/07/2016, 14:30 - 15:45, Hall B (Poster Area)
    • +

      P3.02c-046 - Safety, Clinical Activity and Biomarker Results from a Phase Ib Study of Erlotinib plus Atezolizumab in Advanced NSCLC

      14:30 - 14:30  |  Author(s): C. Rudin

      • Abstract

      Loading...